AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financial statements, including revenue, expenses, profit, and loss

The total revenue of 0A8M for the last quarter is 22.93 M USD, and it's 3.78% higher compared to the previous quarter. The net income of Q2 24 is -220.00 k USD.